Provectus Biopharmaceuticals Inc (NYSE MKT LLC:PVCT)

0.88
Delayed Data
As of Feb 26
 -0.01 / -1.12%
Today’s Change
0.30
Today|||52-Week Range
3.75
+10.00%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Wachter Eric A
Chief Technology Officer
Buy3/20/2014600,000$0.93$558.0K-63.33%
Wachter Eric A
Chief Technology Officer
Buy1/24/2015185,000$1.02$188.7K+11.39%
Culpepper Peter R
Chief Financial & Operating Officer
Buy6/28/2014100,000$1.25$125.0K+2.33%
Scott Timothy C
President
Buy12/30/2014126,361$0.64$80.9K+11.39%
Scott Timothy C
President
Buy10/29/201496,875$0.64$62.0K+2.31%
Scott Timothy C
President
Buy1/07/201576,764$0.64$49.1K+7.33%
Culpepper Peter R
Chief Financial & Operating Officer
Buy1/07/201529,786$0.94$28.0K+7.33%
Culpepper Peter R
Chief Financial & Operating Officer
Buy1/07/201533,334$0.75$25.0K+7.33%
Wachter Eric A
Chief Technology Officer
Buy3/20/201425,000$0.95$23.8K-63.33%
Scott Timothy C
President
Buy5/19/201425,000$0.95$23.8K-70.76%
Page of 2

To view my watchlist

Not a member yet?

Sign up now for a free account